Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-07-02)

USD 16.77+5.14%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

8.75%1Y

6.75%3Y

-0.59%5Y

Performance

20.5%1Y

19.4%3Y

19.8%5Y

Volatility

52988 M

Market cap (USD)

3,515,153

Daily traded volume (Shares)

13.25 / 13.155

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Adam Hakimi Bin Hasni

United Kingdom, 04 Nov 2025

A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan

sofia nava

Switzerland, 29 Oct 2025

.

EQUITIES OF THE SAME SECTOR

Pacira BioSciences Inc

Pacira BioSciences Inc Valor: 12338490

Annual Return

-50%0%+50%

Risk level

110

1.44%USD 25.39

Terveystalo Oyj

Terveystalo Oyj Valor: 37893402

Annual Return

-50%0%+50%

Risk level

110

-0.39%EUR 7.73

Siemens Healthineers AG

Siemens Healthineers AG Valor: 40652181

Annual Return

-50%0%+50%

Risk level

110

0.03%EUR 34.97

Beiersdorf AG

Beiersdorf AG Valor: 324660

Annual Return

-50%0%+50%

Risk level

110

-0.21%EUR 76.52

Merck KGaA

Merck KGaA Valor: 412799

Annual Return

-50%0%+50%

Risk level

110

-1.25%EUR 145.65

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG Valor: 1055489

Annual Return

-50%0%+50%

Risk level

110

3.83%EUR 28.74

Boston Scientific Corp

Boston Scientific Corp Valor: 913577

Annual Return

-50%0%+50%

Risk level

110

4.83%USD 45.14

Sienna Senior Living Inc

Sienna Senior Living Inc Valor: 28093100

Annual Return

-50%0%+50%

Risk level

110

2.29%CAD 23.26

Icon PLC

Icon PLC Valor: 1017575

Annual Return

-50%0%+50%

Risk level

110

-1.14%USD 173.06

Abbott India Limited

Abbott India Limited Valor: 561999

Annual Return

-50%0%+50%

Risk level

110

0.50%INR 25,850.45

SIX

FactSet

Clearbit

Logos provided by Clearbit